about
Isoniazid-gelatin conjugate microparticles containing rifampicin for the treatment of tuberculosis.Molecular arrangements and interconnected bilayer formation induced by alcohol or polyalcohol in phospholipid vesicles.Development of novel diolein-niosomes for cutaneous delivery of tretinoin: influence of formulation and in vitro assessment.Faceted phospholipid vesicles tailored for the delivery of Santolina insularis essential oil to the skin.Santosomes as natural and efficient carriers for the improvement of phycocyanin reepithelising ability in vitro and in vivo.Functional response of novel bioprotective poloxamer-structured vesicles on inflamed skin.Fabrication of polyelectrolyte multilayered vesicles as inhalable dry powder for lung administration of rifampicin.Rifampicin-loaded liposomes for the passive targeting to alveolar macrophages: in vitro and in vivo evaluation.Chitosan-coated liposomes for delivery to lungs by nebulisation.PLGA, chitosan or chitosan-coated PLGA microparticles for alveolar delivery? A comparative study of particle stability during nebulization.Improving oral bioavailability and pharmacokinetics of liposomal metformin by glycerolphosphate-chitosan microcomplexation.Identification and nanoentrapment of polyphenolic phytocomplex from Fraxinus angustifolia: in vitro and in vivo wound healing potential.Diclofenac-beta-cyclodextrin binary systems: physicochemical characterization and in vitro dissolution and diffusion studies.Composition influence on pulmonary delivery of rifampicin liposomesClose-packed vesicles for diclofenac skin delivery and fibroblast targeting.Delivery of liquorice extract by liposomes and hyalurosomes to protect the skin against oxidative stress injuries.Release of rifampicin from chitosan, PLGA and chitosan-coated PLGA microparticles.Effect of diclofenac and glycol intercalation on structural assembly of phospholipid lamellar vesicles.Nutriosomes: prebiotic delivery systems combining phospholipids, a soluble dextrin and curcumin to counteract intestinal oxidative stress and inflammation.Antimalarial Activity of Orally Administered Curcumin Incorporated in Eudragit®-Containing Liposomes.Chitosomes as drug delivery systems for C-phycocyanin: Preparation and characterizationExtract Loaded in Vesicular Systems for the Protection of Oral CavityNanocrystals as tool to improve piroxicam dissolution rate in novel orally disintegrating tabletsDevelopment of curcumin loaded sodium hyaluronate immobilized vesicles (hyalurosomes) and their potential on skin inflammation and wound restoringEffects of ethanol and diclofenac on the organization of hydrogenated phosphatidylcholine bilayer vesicles and their ability as skin carriersImprovement of quercetin protective effect against oxidative stress skin damages by incorporation in nanovesiclesGlycerosomes: A new tool for effective dermal and transdermal drug deliveryLiposomes Coated with Chitosan–Xanthan Gum (Chitosomes) as Potential Carriers for Pulmonary Delivery of RifampicinPhysicochemical, Cytotoxic, and Dermal Release Features of a Novel Cationic Liposome NanocarrierCo-Loading of Ascorbic Acid and Tocopherol in Eudragit-Nutriosomes to Counteract Intestinal Oxidative StressTocopherol-loaded transfersomes: In vitro antioxidant activity and efficacy in skin regenerationPreparation of gellan-cholesterol nanohydrogels embedding baicalin and evaluation of their wound healing activityAntimicrobial Effect of Thymus capitatus and Citrus limon var. pompia as Raw Extracts and Nanovesicles.Comparison between Citral and Pompia Essential Oil Loaded in Phospholipid Vesicles for the Treatment of Skin and Mucosal InfectionsEco-scalable baicalin loaded vesicles developed by combining phospholipid with ethanol, glycerol, and propylene glycol to enhance skin permeation and protectionBaicalin and berberine ultradeformable vesicles as potential adjuvant in vitiligo therapyMangiferin glycethosomes as a new potential adjuvant for the treatment of psoriasisIncorporation of Lippia citriodora Microwave Extract into Total-Green Biogelatin-Phospholipid Vesicles to Improve Its Antioxidant ActivityOptimization of Innovative Three-Dimensionally-Structured Hybrid Vesicles to Improve the Cutaneous Delivery of Clotrimazole for the Treatment of Topical CandidiasisSalmeterol Xinafoate (SX) loaded into mucoadhesive solid lipid microparticles for COPD treatment
P50
Q34910919-2AA68C63-BC1A-4ABC-8D21-5644E8904066Q35134803-D2E5DD81-406D-4E32-9F9D-B018203C2260Q35471066-69160999-EAD9-4371-AD3A-54920FB35F8DQ35657962-C71DDCEE-719A-4204-A855-B4379352A0C6Q35979661-C2D82CAD-CD66-46E6-86A5-A40BFACDA067Q38722446-068AD60F-950B-45ED-91B2-862E955BAEB2Q38984966-74436B53-D02F-472E-9A87-7053990E9628Q39839885-45360B67-2F3D-47FA-B657-6E06384254FCQ39886125-5D1BF7E8-F795-4D7D-BE64-E4803F531699Q40048971-2610A841-D0DC-4D5A-85E4-3C1399FC165DQ41125054-4545B710-D514-4114-92DC-A242F52CEFB4Q41606778-FEBB0EDF-1477-4F22-8DF5-44112D4B30BFQ41854263-8E41BEAF-8787-44E2-AB08-F73A71450117Q42087785-0BC2247E-CF16-4B12-87D7-5891DB4E7572Q42815701-EA1D4A6B-316F-44F5-AF6C-C7D6AFC321D9Q42820248-17709268-16DD-4AFC-8AD6-F2B6F1DE6C77Q46331382-BBDBC353-757D-459B-B8F5-781C16F02631Q46363165-4EA7B08C-DF8C-4595-8214-5FA6BDBE53C7Q47723451-F2C84C97-FC9A-4066-8F9D-0917792B6C13Q53820019-239C48B5-BF6E-4A27-8DA6-AEF4FE937362Q57362802-F6FC05D1-FE15-4BEE-8A05-F49F1E7FC72CQ57467596-90E17F56-AF05-4CA4-8337-6FFC36DCE9B3Q59594838-4169B3B8-6CFC-45D6-B1DA-D7FA428BA1D0Q61160052-B96E1D4F-C0A3-4A0B-9F38-2D7D7AD54225Q61160053-37155866-D7A6-4AFE-BC51-14E1067C1014Q61160072-6113F844-A7AF-4B19-BF1C-A9FA3D5D19DCQ61160075-66EF0100-AABA-487E-82D8-DB530EEF735FQ61160087-37E01AD5-A2BE-48B3-B3E8-701E7C754F33Q61412388-0668258D-4BFD-491B-A3CF-9160CD361247Q61806423-C2326186-35A4-468B-98B4-C3B71C8C8D27Q63258119-4B1C6960-D47D-4F8F-AD0B-1FA1C05D621AQ63258120-20883EAC-1185-41E2-8BC3-5C7714F37C88Q65002639-290A47F2-CEFA-4A0E-8FDA-BCA08A9AD1E5Q89659212-97612AB8-B734-4F45-8543-9CC51B1D25C8Q90191855-683515EA-CF29-4D31-86C8-FFF13F794D1FQ90778594-3D7764F2-695D-4DF7-BC33-BE3CBFBE8055Q91374733-18073174-1669-400C-88F5-7FE751DEF222Q92120877-DA0B92F9-7FE1-4573-B1F4-A5F14F99F69EQ92589514-2A488ADB-7588-4DE5-A9F8-CDB499DA0E58Q92763734-91D5CD6C-A8C8-417E-ACEA-6BD8F2D493CF
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Maria Letizia Manca
@ast
Maria Letizia Manca
@en
Maria Letizia Manca
@es
Maria Letizia Manca
@sl
type
label
Maria Letizia Manca
@ast
Maria Letizia Manca
@en
Maria Letizia Manca
@es
Maria Letizia Manca
@sl
prefLabel
Maria Letizia Manca
@ast
Maria Letizia Manca
@en
Maria Letizia Manca
@es
Maria Letizia Manca
@sl
P106
P1153
9237872000
P21
P31
P496
0000-0002-3787-257X